Although all unimolecular triple agonists in phase 2 trials for obesity are GLP1/GIP/GCG triple agonists, there is an ongoing phase 2 clinical trial of bioglutide, an oral insulin-like-growth factor-1 (IGF-1)/GLP-1/GIP/GCG quadruple agonist (NCT06564753) for individuals with obesity, which is also being trialled in combination with tirzepatide (NCT06643728)
If youre embarking on a weight loss program, we want you to lean on lipotropes, which are substances that promote fat removal and reduce fat production in your body
Its also known to decrease because of infection and chronic disease
Adipotide, conversely, gained prominence following a landmark study in Science Translational Medicine involving spontaneous obese rhesus monkeys
Well, NAD+ is a fundamental coenzyme found in every cell of your body, playing a pivotal role in countless metabolic processes, including energy production, DNA repair, and cellular signaling